Effect of age on efficacy and safety of vorapaxar in patients with non–ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial-Reference-Cited by-同舟云学术

Effect of age on efficacy and safety of vorapaxar in patients with non–ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

Published:2016-08 Issue: Volume:178 Page:176-184
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Armaganijan Luciana V.,Alexander Karen P.,Huang Zhen,Tricoci Pierluigi,Held Claes,Van de Werf Frans,Armstrong Paul W.,Aylward Philip E.,White Harvey D.,Moliterno David J.,Wallentin Lars,Chen Edmond,Harrington Robert A.,Strony John,Mahaffey Kenneth W.,Lopes Renato D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Issues with care in the elderly patient presenting with acute ischemia;Gharacholou;Curr Heart Fail Rep,2006

2. Evolution in cardiovascular care for elderly patients with non–ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative;Alexander;J Am Coll Cardiol,2005

3. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE);Brieger;Am Heart J,2007

4. Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy;Januzzi;Am J Cardiol,2003

5. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE);Avezum;Am Heart J,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis;Clinical Science;2020-11

2. Molecular Drivers of Platelet Activation: Unraveling Novel Targets for Anti-Thrombotic and Anti-Thrombo-Inflammatory Therapy;International Journal of Molecular Sciences;2020-10-24

3. Challenges and Controversies in the Management of ACS in Elderly Patients;Current Cardiology Reports;2020-06-04

4. Evidence in Guidelines for Treatment of Coronary Artery Disease;Advances in Experimental Medicine and Biology;2020

5. Optimised care of elderly patients with acute coronary syndrome;European Heart Journal: Acute Cardiovascular Care;2018-03-05